BARCELONA -- The oral drug deucravacitinib (Sotyktu) passed what is probably its final test as a treatment for psoriatic ...

Called enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic ...

Wade, Medicaid expansion, marijuana decriminalization, and the rights of same-sex couples prior to Obergefell v. Hodges. Now, ...

Cuts to Medicaid and other federal health programs proposed in President Donald Trump's budget plan would rapidly push more ...

Federal investigators found that a pilot's medication use may have been a contributing factor in a 2023 medical helicopter ...

Causes of brain injury included hemorrhagic stroke in 53% of patients, anoxic brain injury in 21%, traumatic brain injury in ...

People reporting cold drinks or foods as triggers for their atrial fibrillation (Afib) were invited to a survey.

Now, with up to 9 years of follow-up, Koray Tascilar, MD, of Friedrich-Alexander-Universität in Erlangen, Germany, said that this preventive effect gradually vanished. The active treatment group still ...

The FLUID trial was designed to fill in the evidence for all the patients in between the ED and intensive care unit (ICU), as ...

HHS Secretary Robert F. Kennedy Jr. announced his decision to "retire" all 17 members of the CDC's Advisory Committee on ...

Note that some links may require registration or subscription. The United Kingdom's Food Standards Agency says that certain ...

In the DESTINY-Breast09 trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, first-line trastuzumab deruxtecan (T-DXd; Enhertu) combined with pertuzumab ...